Buscar resultados de ensayos clínicos
Hepatolenticular Degeneration - 16 Studies Found
Estado | Estudiar |
Completed |
Nombre del estudio: Single Daily Dosage of Trientine for Maintenance Treatment for Wilson Disease Condición: Wilson Disease Fecha: 2011-11-11 Intervenciones: Drug: Once a day Trientine Trientine at a dosage of ~15 mg/kg rounded upwards to the nearest 250 or 300 |
Active, not recruiting |
Nombre del estudio: The Assessment of Copper Parameters in Wilson Disease Subjects on Standard of Care Treatment Condición: Wilson Disease Fecha: 2016-05-03 |
Completed |
Nombre del estudio: Efficacy and Safety, Long-term Study of Zinc Acetate to Treat Wilson's Disease in Japan. Condición: Wilson's Disease Fecha: 2005-09-13 Intervenciones: Drug: NPC-02 zinc acetate |
Active, not recruiting |
Nombre del estudio: Efficacy and Safety Study of WTX101 in Adult Wilson Disease Patients Condición: Wilson Disease Fecha: 2014-10-20 Intervenciones: Drug: WTX101 Dosage Form: 15 mg Tablets |
Recruiting |
Nombre del estudio: sCD163 and sMR in Wilsons Disease - Associations With Disease Severity and Fibrosis Condición: Wilsons Disease Fecha: 2016-02-26 Intervenciones:
|
Completed |
Nombre del estudio: A Phase 1 Study to Assess the Effects in the Body of a Single Dose of Trientine Dihydrochloride in Wilson's Disease Patients Condición: Wilson's Disease Fecha: 2013-06-06 Intervenciones: Drug: trientine dihydrochloride Patients will take their normal prescribed dose (x1) of trientine dihydr |
Recruiting |
Nombre del estudio: Study to Assess Long-Term Outcomes of Trientine in Wilson Disease Patients Withdrawn From Therapy With d-Penicillamine Condición: Wilson Disease Fecha: 2014-09-18 Intervenciones: Drug: trientine dihydrochloride A retrospective review of patients' medical records |
Completed |
Nombre del estudio: Study of Zinc for Wilson Disease Condición: Wilson Disease Fecha: 1999-10-18 Intervenciones: Drug: zinc acetate |
Completed |
Nombre del estudio: Study of Tetrathiomolybdate in Patients With Wilson Disease Condición: Wilson Disease Fecha: 1999-10-18 Intervenciones:
|
Completed |
Nombre del estudio: Efficacy of Invitro Expanded Bone Marrow Derived Allogeneic Mesenchymal Stem Cell Transplantation Via Portal Vein or Hepatic Artery or Peripheral Vein in Patients With Wilson Cirrhosis Condición: Wilson's Disease Fecha: 2011-06-20 Intervenciones: Genetic: allogeneic mesenchymal stem cell transplantation 1.000.000(one million) cells/kg, IV (1/2 of do |